COMMUNIQUÉS West-GlobeNewswire

Intra-Cellular Therapies Presents Data on Symptom Improvement by Lumateperone on Negative Symptoms, Depression, and Social Function in Patients with Schizophrenia at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
31/05/2018
NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, announced [...]
Natus Medical Highlights Board’s Strengths and Management’s Track Record of Value Creation in Investor Presentation
31/05/2018
Outlines Ongoing, Successful Execution of Strategic Plan Board Urges Shareholders to Vote on the WHITE Proxy Card FOR the Election of Doris Engibous and Robert Weiss TODAY Shareholders Should Not Vote for Removal of [...]
SoldierStrong to Host Benefit for Veterans and Honor Leora and Steven Levy
31/05/2018
Fox News’ Dana Perino to Deliver Keynote Address at Event Saluting the Nonprofit’s Notable Supporters STAMFORD, Conn., May 31, 2018 (GLOBE NEWSWIRE) -- SoldierStrong, a nonprofit organization dedicated to providing [...]
Biotricity Achieves Revenue Generation and Market Expansion with Anchor Clients
31/05/2018
REDWOOD CITY, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]
Entellus Medical Announces Multi-Center Clinical Study Publication Confirming Nasal Obstruction Symptom Improvement from LATERA
31/05/2018
MENLO PARK, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Entellus Medical, Inc., now a part of Stryker, today announced the publication of positive data from prospective, multicenter OR and Office studies of LATERA for [...]
Inovio CEO to Speak on Viral Epidemic Preparedness Panel at BIO International Convention
31/05/2018
PLYMOUTH MEETING, Pa., May 31, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that Dr. J. Joseph Kim, President and CEO, will address Inovio’s ability to respond to emerging viral [...]
Cambrex Invests $5 Million in New Laboratory Expansion at its Karlskoga, Sweden Facility
31/05/2018
EAST RUTHERFORD, N.J., May 31, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]
Zynerba Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference
31/05/2018
DEVON, Pa., May 31, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE ), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative [...]
Radient Technologies Inc. Provides Corporate Update on Expansion and ACMPR License Approval
31/05/2018
EDMONTON, Alberta, May 31, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture:RTI) is pleased to provide an update on its manufacturing facility expansion, pending ACMPR license [...]
Sonoma Pharmaceuticals Announces Fiscal Year/Fourth Quarter 2018 Financial Results and Conference Call
31/05/2018
PETALUMA, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA ), today announced that financial results for its fiscal fourth quarter 2018, ended March 31, 2018, will be released after [...]
GeneSight® Guided Treatment Significantly Improves Outcomes for Patients with Major Depression Treated in the Primary Care Setting
31/05/2018
New Results from the IMPACT Study to be Presented at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting SALT LAKE CITY, May 31, 2018 (GLOBE NEWSWIRE) -- Assurex Health, a wholly-owned subsidiary [...]
Nasdaq Approves Listing of IMV Inc. Common Shares
31/05/2018
HALIFAX, Nova Scotia, May 31, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (“IMV” or the “Corporation”) (TSX: IMV ) (OTCQX:IMMVD), a clinical stage immunotherapy company, today announced that its common shares have been approved [...]
APTOSE Enters into US$20 Million Common Share Purchase Agreement with Aspire Capital Fund, LLC
31/05/2018
SAN DIEGO and TORONTO, May 31, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics that target [...]
Innovate Biopharmaceuticals Scheduled to Present at the Jefferies Global Healthcare Conference in New York on Friday, June 8, 2018, at 11:30AM
31/05/2018
RALEIGH, N.C., May 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT ), a clinical stage biotechnology company focused on developing novel therapeutics for immuno-inflammatory [...]
ObsEva SA to Participate in Jefferies Global Healthcare Conference June 5-8, 2018
31/05/2018
Geneva, Switzerland and Boston, MA -May 31, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that [...]
Merus to Present at the Jefferies 2018 Healthcare Conference
31/05/2018
UTRECHT, The Netherlands, May 31, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS ), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics ® ), today announced that [...]
Nabriva Therapeutics to Present Lefamulin Data at ASM Microbe
31/05/2018
Potential of Lefamulin to Treat Patients with CABP Against Backdrop of Increasing Bacterial Resistance Presented on Eight Posters DUBLIN, Ireland, May 31, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV [...]
miRagen Therapeutics to Present at Jefferies 2018 Global Healthcare Conference on Thursday, June 7th
31/05/2018
BOULDER, Colo., May 31, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today [...]
T2 Biosystems Announces Pricing of Public Offering of Common Stock
31/05/2018
LEXINGTON, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ) today announced the pricing of an underwritten registered public offering of 6,100,000 shares of common stock at a public offering [...]

Pages